Stockscreener 앱 받기
14.97
0.86%
-0.13
전일 마감가:
$15.10
열려 있는:
$15.14
하루 거래량:
110.33K
Relative Volume:
0.64
시가총액:
$1.01B
수익:
-
순이익/손실:
$-46.13M
주가수익비율:
-18.43
EPS:
-0.8123
순현금흐름:
$-34.10M
1주 성능:
-6.85%
1개월 성능:
-2.16%
6개월 성능:
-23.52%
1년 성능:
-6.20%
1일 변동 폭
$14.80
$15.38
1주일 범위
$14.80
$16.21
52주 변동 폭
$13.50
$25.00
펄스 바이오 Stock (PLSE) Company Profile
명칭
Pulse Biosciences Inc
전화
510-906-4600
주소
3957 POINT EDEN WAY, HAYWARD, CA
PLSE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PLSE
Pulse Biosciences Inc
|
14.97 | 1.08B | 0 | -46.13M | -34.10M | -0.8123 |
|
ISRG
Intuitive Surgical Inc
|
516.12 | 185.10B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
175.33 | 50.76B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.16 | 43.19B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
261.07 | 37.26B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
210.08 | 16.13B | 2.90B | 467.20M | 306.90M | 6.37 |
펄스 바이오 Stock (PLSE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-07 | 개시 | Oppenheimer | Outperform |
| 2021-07-27 | 개시 | Stephens | Overweight |
| 2021-03-11 | 개시 | Maxim Group | Buy |
| 2021-01-26 | 재확인 | H.C. Wainwright | Buy |
| 2020-05-12 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-02-14 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2019-02-25 | 개시 | H.C. Wainwright | Buy |
모두보기
펄스 바이오 주식(PLSE)의 최신 뉴스
What analysts say about Pulse Biosciences Inc. stockUnmatched market gains - jammulinksnews.com
What drives Pulse Biosciences Inc. stock priceDynamic portfolio growth - Autocar Professional
Pulse Biosciences Inc. Stock Analysis and ForecastRapid portfolio appreciation - PrintWeekIndia
Is Pulse Biosciences Inc. a good long term investmentTremendous wealth creation - jammulinksnews.com
Should I buy Pulse Biosciences Inc. stock before earningsFree Deep Market Trend Analysis - Newser
How Pulse Biosciences Inc. stock performs during market volatilityDaily Top Gainers - beatles.ru
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 16, 2025 - BioSpace
What makes Pulse Biosciences Inc. stock price move sharplyBreakout Momentum Alerts - Newser
Why Pulse Biosciences Inc. stock attracts strong analyst attentionFree Deep Market Trend Analysis - Newser
Pulse Biosciences Appoints New VP of Accounting - TipRanks
Pulse Biosciences appoints Steven T. Weber as principal accounting officer - Investing.com
Don't Ignore The Insider Selling In Pulse Biosciences - 富途牛牛
(PLSE) Proactive Strategies - news.stocktradersdaily.com
Pulse Biosciences stock initiated at Outperform by Oppenheimer on nsPFA potential - Investing.com Canada
Oppenheimer initiates coverage on Pulse Biosciences with an Outperform rating, $22 PT. - AInvest
Oppenheimer & Co. Inc. Sells 5,000 Shares of Pulse Biosciences, Inc (NASDAQ:PLSE) - Defense World
(PLSE) Long Term Investment Analysis - news.stocktradersdaily.com
GAMMA Investing LLC Boosts Stock Position in Pulse Biosciences, Inc (NASDAQ:PLSE) - Defense World
Farther Finance Advisors LLC Has $143,000 Stock Holdings in Pulse Biosciences, Inc (NASDAQ:PLSE) - Defense World
Insider Sell: Darrin Uecker Sells 30,000 Shares of Pulse Bioscie - GuruFocus
Pulse Biosciences, Inc. (NASDAQ:PLSE) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Nuveen Asset Management LLC Has $990,000 Stock Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
BNP Paribas Financial Markets Has $35,000 Holdings in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Deutsche Bank AG Boosts Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listi - GuruFocus
Bank of America Corp DE Has $13.73 Million Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences, Inc. (NASDAQ:PLSE) insiders have significant skin in the game with 73% ownership - Yahoo Finance
Tower Research Capital LLC TRC Has $29,000 Stock Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Transcript : Pulse Biosciences, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 05 - marketscreener.com
펄스 바이오 (PLSE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
펄스 바이오 주식 (PLSE) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| UECKER DARRIN | Chief Technology Officer |
Jun 13 '25 |
Sale |
15.98 |
15,000 |
239,700 |
122,872 |
1.28%
자본화:
|
볼륨(24시간):